CEP
LLY icon

Chicago Equity Partners’s Eli Lilly LLY Stock Holding History

Chicago Equity Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$2.03M Sell
14,620
-4,035
-22% -$554K 0.2% 139
2019
Q4 		$2.45M Sell
18,655
-2,035
-10% -$236K 0.14% 216
2019
Q3 		$2.31M Buy
20,690
+1,625
+9% +$181K 0.11% 277
2019
Q2 		$2.11M Buy
19,065
+665
+4% +$78.3K 0.09% 316
2019
Q1 		$2.39M Sell
18,400
-6,425
-26% -$781K 0.09% 305
2018
Q4 		$2.87M Sell
24,825
-11,885
-32% -$1.33M 0.12% 255
2018
Q3 		$3.94M Buy
36,710
+6,760
+23% +$676K 0.12% 242
2018
Q2 		$2.56M Buy
29,950
+11,845
+65% +$973K 0.08% 336
2018
Q1 		$1.4M Buy
18,105
+4,965
+38% +$400K 0.04% 440
2017
Q4 		$1.11M Buy
13,140
+9,260
+239% +$788K 0.03% 480
2017
Q3 		$332K Buy
3,880
+650
+20% +$53.3K 0.01% 675
2017
Q2 		$266K Sell
3,230
-130
-4% -$10.6K 0.01% 708
2017
Q1 		$283K Buy
3,360
+355
+12% +$28.4K 0.01% 670
2016
Q4 		$221K Sell
3,005
-17,650
-85% -$1.31M 0.01% 692
2016
Q3 		$1.66M Buy
20,655
+13,575
+192% +$1.09M 0.05% 341
2016
Q2 		$558K Sell
7,080
-2,320
-25% -$175K 0.02% 486
2016
Q1 		$677K Sell
9,400
-4,485
-32% -$339K 0.02% 416
2015
Q4 		$1.17M Buy
13,885
+4,930
+55% +$409K 0.03% 336
2015
Q3 		$749K Buy
8,955
+5,555
+163% +$469K 0.02% 418
2015
Q2 		$284K Sell
3,400
-245
-7% -$18.7K 0.01% 407
2015
Q1 		$265K Sell
3,645
-555
-13% -$39.5K 0.01% 405
2014
Q4 		$290K Sell
4,200
-2,330
-36% -$157K 0.01% 350
2014
Q3 		$423K Sell
6,530
-2,395
-27% -$152K 0.01% 344
2014
Q2 		$554K Sell
8,925
-231,040
-96% -$13.8M 0.01% 308
2014
Q1 		$14.1M Sell
239,965
-24,230
-9% -$1.35M 0.39% 86
2013
Q4 		$13.5M Sell
264,195
-161,890
-38% -$8.11M 0.4% 90
2013
Q3 		$21.4M Buy
426,085
+18,175
+4% +$952K 0.66% 50
2013
Q2 		$20M Buy
+407,910
New +$22.2M 0.62% 54

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Chicago Equity Partners's LLY Position: Q1 2020 in Review

Chicago Equity Partners reduced its Eli Lilly (LLY) stake by 22% in Q1 2020, selling an estimated $554K and leaving 14,620 shares worth $2.03M. The position accounts for 0.2% of the portfolio, ranked #139.

Chicago Equity Partners first reported a position in LLY in Q2 2013 and has held it in 28 quarters since. The position peaked at $21.4M in Q3 2013. 1,684 funds tracked by Wall St. Rank hold LLY as of Q1 2020.

  • Chicago Equity Partners held 14,620 shares of Eli Lilly worth $2.03M as of Q1 2020.
  • Chicago Equity Partners sold 4,035 Eli Lilly shares in Q1 2020, an estimated $554K.
  • Eli Lilly made up 0.2% of Chicago Equity Partners's portfolio in Q1 2020, its #139 holding.
  • Chicago Equity Partners first reported a position in Eli Lilly in Q2 2013 and has held it in 28 quarters since.
  • Chicago Equity Partners's Eli Lilly position peaked at $21.4M in Q3 2013.
  • 1,684 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.